Localization of functional domains in the androgen receptor

Journal of Steroid Biochemistry and Molecular Biology

Volumn 62, Issue 4, 1997, Pages 233-242

  MacLean, Helen E ^a   Warne, Garry L ^a   Zajac, Jeffrey D ^b  

^a ROYAL CHILDREN'S HOSPITAL   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR;

AMINO ACID SEQUENCE; BINDING SITE; CYTOCHEMISTRY; DNA BINDING; GENE MUTATION; HUMAN; IN VITRO STUDY; LIGAND BINDING; MALE; MUTAGENESIS; NONHUMAN; PROSTATE; PROTEIN DOMAIN; REVIEW; TRANSACTIVATION;

BINDING SITES; CELL NUCLEUS; DIMERIZATION; DNA-BINDING PROTEINS; HEAT-SHOCK PROTEINS; HUMANS; LIGANDS; MOLECULAR CHAPERONES; PHOSPHORYLATION; PROMOTER REGIONS (GENETICS); PROTEIN STRUCTURE, TERTIARY; RECEPTORS, ANDROGEN; RECEPTORS, STEROID; TRANS-ACTIVATION (GENETICS);

EID: 0030785063     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-0760(97)00049-6     Document Type: Review

References (96)

1. Glass C. K., Differential recognition of target genes by nuclear receptor monomers, dimers and heterodimers. Endocrine Reviews 15 (1994) 391-407.
2. Chambon P., A decade of molecular biology of retinoic acid receptors. FASEB Journal 10 (1996) 940-954.
3. Colvard D. S. and Wilson E. M., Transformation of the 10S androgen receptor in a hamster ductus deferens tumor cell line. Endocrinology 121 (1987) 931-940.
4. Grino P. B., Griffin J. E. and Wilson J. D., Transformation of the androgen receptor to the deoxyribonucleic acid-binding state: studies in homogenates and intact cells. Endocrinology 120 (1987) 1914-1920.
5. Kuil C. W., Berrevoets C. A. and Mulder E., Ligand-induced conformational alterations of the androgen receptor analyzed by limited trypsinization. Studies on the mechanism of antiandrogen action. Journal of Biological Chemistry 270 (1995) 27569-27576.
6. Bourguet W., Ruff M., Chambon P., Gronemeyer H. and Moras D., Crystal structure of the ligand-binding domain of the human nuclear receptor RXR-α. Nature 375 (1995) 377-382.
7. Lubahn D. B., Brown T. R., Simental J. A., Higgs H. N., Migeon C. J., Wilson E. M. and French F. S., Sequence of the intron/exon junctions of the coding region of the human androgen receptor gene and identification of a point mutation in a family with complete androgen insensitivity. Proceedings of the National Academy of Sciences of the U.S.A. 86 (1989) 9534-9538.
8. Renaud J. P., Rochel N., Ruff M., Vivat V., Chambon P., Gronemeyer H. and Moras D., Crystal structure of the RAR-γ ligand-binding domain bound to all-trans retinoic acid. Nature 378 (1995) 681-689.
9. Wagner R. L., Apriletti J. W., McGrath M. E., West B. L., Baxter J. D. and Fletterick R. J., A structural role for hormone in the thyroid hormone receptor. Nature 378 (1995) 690-697.
10. Deslypere J. P., Young M., Wilson J. D. and McPhaul M. J., Testosterone and 5 α-dihydrotestosterone interact differently with the androgen receptor to enhance transcription of the MMTV-CAT reporter gene. Molecular and Cellular Endocrinology 88 (1992) 15-22.
11. Wilson E. M. and French F. S., Binding properties of androgen receptors. Evidence for identical receptors in rat testis, epididymis, and prostate. Journal of Biological Chemistry 251 (1976) 5620-5629.
12. Wilbert D. M., Griffin J. E. and Wilson J. D., Characterization of the cytosol androgen receptor of the human prostate. Journal of Clinical Endocrinology and Metabolism 56 (1983) 113-120.
13. Zhou Z. X., Lane M. V., Kemppainen J. A., French F. S. and Wilson E. M., Specificity of ligand-dependent androgen receptor stabilization: receptor domain interactions influence ligand dissociation and receptor stability. Molecular Endocrinology 9 (1995) 208-218.
14. Kemppainen J. A., Lane M. V., Sar M. and Wilson E. M., Androgen receptor phosphorylation, turnover, nuclear transport, and transcriptional activation. Specificity for steroids and antihormones. Journal of Biological Chemistry 267 (1992) 968-974.
15. George F. W., Russell D. W. and Wilson J. D., Feed-forward control of prostate growth: dihydrotestosterone induces expression of its own biosynthetic enzyme, steroid 5α-reductase. Proceedings of the National Academy of Sciences of the U.S.A. 88 (1991) 8044-8047.
16. Umesono K. and Evans R. M., Determinants of target gene specificity for steroid/thyroid hormone receptors. Cell 57 (1989) 1139-1146.
17. Danielsen M., Hinck L. and Ringold G. M., Two amino acids within the knuckle of the first zinc finger specify DNA response element activation by the glucocorticoid receptor. Cell 57 (1989) 1131-1138.
18. Mader S., Kumar V., de Verneuil H. and Chambon P., Three amino acids of the oestrogen receptor are essential to its ability to distinguish an oestrogen from a glucocorticoid-responsive element. Nature 338 (1989) 271-274.
19. Luisi B. F., Xu W. X., Otwinowski Z., Freedman L. P., Yamamoto K. R. and Sigler P. B., Crystollographic analysis of the interaction of the glucocorticoid receptor with DNA. Nature 352 (1991) 497-505.
20. Beato M., Gene regulation by steroid hormones. Cell 56 (1989) 335-344.
21. Kasper S., Rennie P. S., Bruchovsky N., Sheppard P. C., Cheng H., Lin L., Shiu R. P., Snoek R. and Matusik R. J., Cooperative binding of androgen receptors to two DNA sequences is required for androgen induction of the probasin gene. Journal of Biological Chemistry 269 (1994) 31763-31769.
22. Warriar N., Yu C., Page N. and Govindan M. V., Substitution of Cys-560 by Phe, Trp, Tyr, and Ser in the first zinc finger of human androgen receptor affects hormonal sensitivity and transcriptional activation. Journal of Biological Chemistry 269 (1994) 29016-29023.
23. Zoppi S., Marcelli M., Deslypere J. P., Griffin J. E., Wilson J. D. and McPhaul M. J., Amino acid substitutions in the DNA-binding domain of the human androgen receptor are a frequent cause of receptor-binding positive androgen resistance. Molecular Endocrinology 6 (1992) 409-415.
24. Baldazzi L., Baroncini C., Pirazzoli P., Balsamo A., Capelli M., Marchetti G., Bernardi F. and Cacciari E., Two mutations causing complete androgen insensitivity: a frame-shift in the steroid binding domain and a Cys → Phe substitution in the second zinc finger of the androgen receptor. Human Molecular Genetics 3 (1994) 1169-1170.
25. Lumbroso S., Lobaccaro J. M., Belon C., Martin D., Chaussain J. L. and Sultan C., A new mutation within the deoxyribonucleic acid-binding domain of the androgen receptor gene in a family with complete androgen insensitivity syndrome. Fertility and Sterility 60 (1993) 814-819.
26. Mowszowicz I., Lee H. J., Chen H. T., Mestayer C., Portois M. C., Cabrol S., Mauvais-Jarvis P. and Chang C., A point mutation in the second zinc finger of the DNA-binding domain of the androgen receptor gene causes complete androgen insensitivity in two siblings with receptor-positive androgen resistance. Molecular Endocrinology 7 (1993) 861-869.
27. Marcelli M., Zoppi S., Grino P. B., Griffin J. E., Wilson J. D. McPhaul M. J., A mutation in the DNA-binding domain of the androgen receptor gene causes complete testicular feminization in a patient with receptor-positive androgen resistance. Journal of Clinical Investigation 87 (1991) 1123-1126.
28. Kallio P. J., Palvimo J. J., Mehto M. and Janne O. A., Analysis of androgen receptor-DNA interactions with receptor proteins produced in insect cells. Journal of Biological Chemistry 269 (1994) 11514-11522.
29. De Vos P., Claessens F., Celis L., Peeters B., Rombauts W., Heyns W. and Verhoeven G., Nuclear extracts enhance the interaction of fusion proteins containing the DNA-binding domain of the androgen and glucocorticoid receptor with androgen and glucocorticoid response elements. Journal of Steroid Biochemistry and Molecular Biology 48 (1994) 317-323.
30. Wong C. I., Zhou Z. X., Sar M. and Wilson E. M., Steroid requirement for androgen receptor dimerization and DNA binding. Modulation by intramolecular interactions between the NH2-terminal and steroid-binding domains. Journal of Biological Chemistry 268 (1993) 19004-19012.
31. Fawell S. E., Lees J. A., White R. and Parker M. G., Characterization and colocalization of steroid binding and dimerization activities in the mouse estrogen receptor. Cell 60 (1990) 953-962.
32. Nemoto T., Ohara-Nemoto Y., Shimazaki S. and Ota M., Dimerization characteristics of the DNA-and steroid-binding domains of the androgen receptor. Journal of Steroid Biochemistry and Molecular Biology 50 (1994) 225-233.
33. Gast A., Neuschmid-Kaspar F., Klocker H. and Cato A. C. B., A single amino acid exchange abolishes dimerization of the androgen receptor and causes Reifenstein syndrome. Molecular and Cellular Endocrinology 111 (1995) 93-98.
34. Bagchi M. K., Tsai M. J., O'Malley B. W. and Tsai S. Y., Analysis of the mechanism of steroid hormone receptor-dependent gene activation in cell-free systems. Endocrine Reviews 13 (1992) 525-535.
35. Ing N. H., Beekman J. M., Tsai S. Y., Tsai M. J. and O'Malley B. W., Members of the steroid hormone receptor superfamily interact with TFIIB (S300-II). Journal of Biological Chemistry 267 (1992) 17617-17623.
36. Mitchell P. J. and Tjian R., Transcriptional regulation in mammalian cells by sequence-specific DNA binding proteins. Science 245 (1989) 371-378.
37. Simental J. A., Sar M., Lane M. V., French F. S. and Wilson E. M., Transcriptional activation and nuclear targeting signals of the human androgen receptor. Journal of Biological Chemistry 266 (1991) 510-518.
38. Jenster G., van der Korput H. A., van Vroonhoven C., van der Kwast T. H., Trapman J. and Brinkmann A. O., Domains of the human androgen receptor involved in steroid binding, transcriptional activation, and subcellular localization. Molecular Endocrinology 5 (1991) 1396-1404.
39. Jenster G., van der Korput H. A., Trapman J. and Brinkmann A. O., Identification of two transcription activation units in the N-terminal domain of the human androgen receptor. Journal of Biological Chemistry 270 (1995) 7341-7346.
40. Chamberlain N. L., Whitacre D. C. and Miesfeld R. L., Delineation of two distinct type 1 activation functions in the androgen receptor amino-terminal domain. Journal of Biological Chemistry 271 (1996) 26772-26778.
41. Gerber H. P., Seipel K., Georgiev O., Hofferer M., Hug M., Rusconi S. and Schaffner W., Transcriptional activation modulated by homopolymeric glutamine and proline stretches. Science 263 (1995) 808-811.
42. Perutz M. F., Johnson T., Suzuki M. and Finch J. T., Glutamine repeats as polar zippers: their possible role in inherited neurodegenerative diseases. Proceedings of the National Academy of Sciences of the U.S.A. 91 (1994) 5355-5358.
43. Chamberlain N. L., Driver E. D. and Miesfeld R. L., The length and location of CAG trinucleotide repeats in the androgen receptor N-terminal domain affect transactivation function. Nucleic Acids Research 22 (1994) 3181-3186.
44. n-expanded neuronopathies. Human Molecular Genetics 4 (1995) 523-527.
45. Jenster G., de Ruiter P. E., van der Korput H. A. G. M., Kuiper G. G. J. M., Trapman J. and Brinkmann A. O., Changes in the abundance of androgen receptor isotypes: effects of ligand treatment, glutamine-stretch variation, and mutation of putative phosphorylation sites. Biochemistry 33 (1994) 14064-14072.
46. Mhatre A. N., Trifiro M. A., Kaufman M., Kazemi-Esfarjani P., Figlewicz D., Rouleau G. and Pinsky L., Reduced transcriptional regulatory competence of the androgen receptor in X-linked spinal and bulbar muscular atrophy. Nature Genetics 5 (1993) 184-188.
47. Peterziel H., Culig Z., Stober J., Hobisch A., Radmayr C., Bartsch G., Klocker H. and Cato A. C. B., Mutant androgen receptors in prostatic tumors distinguish between amino-acid-sequence requirements for transactivation and ligand binding. International Journal of Cancer 63 (1995) 544-550.
48. Kupfer S. R., Marschke K. B., Wilson E. M. and French F. S., Receptor accessory factor enhances specific DNA binding of androgen and glucocorticoid receptors. Journal of Biological Chemistry 268 (1993) 17519-17527.
49. Kupfer S. R., Wilson E. M. and French F. S., Androgen and glucocorticoid receptors interact with insulin degrading enzyme. Journal of Biological Chemistry 269 (1994) 20622-20628.
50. Oñate S. A., Tsai S. Y., Tsai M. J. and O'Malley B. W., Sequence and characterization of a coactivator for the steroid hormone receptor superfamily. Science 270 (1995) 1354-1357.
51. Voegel J. J., Heine M. J. S., Zechel C., Chambon P. and Gronemeyer H., TIF2, a 160 kDa transcriptional mediator for the ligand-dependent activation function AF-2 of nuclear receptors. EMBO Journal 15 (1996) 3667-3675.
52. Hong H., Kohli K., Trivedi A., Johnson D. L. and Stallcup M. R., GRIP1, a novel mouse protein that serves as a transcriptional coactivator in yeast for the hormone binding domains of steroid receptors. Proceedings of the National Academy of Sciences of the U.S.A. 93 (1996) 4948-4952.
53. 70, for the androgen receptor in human prostate cells. Proceedings of the National Academy of Sciences of the U.S.A. 93 (1996) 5517-5521.
54. Husmann D. A., Wilson C. M., McPhaul M. J., Tilley W. D. Wilson J. D., Antipeptide antibodies to two distinct regions of the androgen receptor localize the receptor protein to the nuclei of target cells in the rat and human prostate. Endocrinology 126 (1990) 2359-2368.
55. Tan J. A., Joseph D. R., Quarmby V. E., Lubahn D. B., Sar M., French F. S. and Wilson E. M., The rat androgen receptor: primary strucutre, autoregulation of its messenger ribonucleic acid, and immunocytochemical localization of the receptor protein. Molecular Endocrinology 2 (1988) 1276-1285.
56. Jenster G., Trapman J. and Brinkmann A. O., Nuclear import of the human androgen receptor. Biochemical Journal 293 (1993) 761-768.
57. Jacobson W., Routledge J., Davies H., Saich T., Hughes I., Brinkmann A., Brown B. and Clarkson P., Localisation of androgen receptors in dermal fibroblasts, grown in vitro, from normal subjects and from patients with androgen insensitivity syndrome. Hormone Research 44 (1995) 75-84.
58. Cadepond F., Gasc J. M., Delahaye F., Jibard N., Schweizer-Groyer G., Segard-Maurel I., Evans R. and Baulieu E. E., Hormonal regulation of the nuclear localization signals of the human glucocorticoid receptor. Experimental Cell Research 201 (1992) 99-108.
59. LeCasse E. C., Lochnan H. A., Walker P. and Lefebvre Y. A., Identification of binding proteins for nuclear localization signals of the glucocorticoid and thyroid hormone receptors. Endocrinology 132 (1993) 1017-1025.
60. Guiochon-Mantel A., Loosfelt H., Lescop P., Sar S., Atger M., Perrot-Applanat M. and Milgrom E., Mechanisms of nuclear localization of the progesterone receptor: evidence for interaction between monomers. Cell 57 (1989) 1147-1154.
61. Luo Z., Rouvinen J. and Maenpaa P. H., A peptide C-terminal to the second Zn finger of human vitamin D receptor is able to specify nuclear localization. European Journal of Biochemistry 223 (1994) 381-387.
62. van Laar J. H., Berrevoets C. A., Trapman J., Zegers N. D. Brinkmann A. O., Hormone-dependent androgen receptor phosphorylation is accompanied by receptor transformation in human lymph node carcinoma of the prostate cells. Journal of Biological Chemistry 266 (1991) 3734-3738.
63. Kuiper G. G., de Ruiter P. E. and Brinkmann A. O., Androgen receptor heterogeneity in LNCaP cells is caused by a hormone-independent phosphorylation step. Journal of Steroid Biochemistry and Molecular Biology 41 (1992) 697-700.
64. Kuiper G. G., de Ruiter P. E., Trapman J., Boersma W. J., Grootegoed J. A. and Brinkmann A. O., Localization and hormonal stimulation of phosphorylation sites in the LNCaP-cell androgen receptor. Biochemical Journal 291 (1993) 95-101.
65. Kuiper G. G. and Brinkmann A. O., Phosphotryptic peptide analysis of the human androgen receptor: detection of a hormone-induced phosphopeptide. Biochemistry 34 (1995) 1851-1857.
66. Zhou Z. X., Kemppainen J. A. and Wilson E. M., Identification of three proline-directed phosphorylation sites in the human androgen receptor. Molecular Endocrinology 9 (1995) 605-615.
67. Denner L. A., Weigel N. L., Maxwell B. L., Schrader W. T. O'Malley B. W., Regulation of progesterone receptor-mediated transcription by phosphorylation. Science 250 (1990) 1740-1743.
68. Power R. F., Mani S. K., Codina J., Conneely O. M. and O'Malley B. W., Dopaminergic and ligand-independent activation of steroid hormone receptors. Science 254 (1991) 1636-1639.
69. Aronica S. M. and Katzenellenbogen B. S., Stimulation of estrogen receptor-mediated transcription and alteration in the phosphorylation state of the rat uterine estrogen receptor by estrogen, cyclic adenosine monophosphate, and insulin-like growth factor-I. Molecular Endocrinology 7 (1993) 743-752.
70. Ikonen T., Palvimo J. J., Kallio P. J., Reinikainen P. and Janne O. A., Stimulation of androgen-regulated transactivation by modulators of protein phosphorylation. Endocrinology 135 (1994) 1359-1366.
71. Nazareth L. V. and Weigel N. L., Activation of the human androgen receptor through a protein kinase A signaling pathway. Journal of Biological Chemistry 271 (1996) 19900-19907.
72. Culig Z., Hobisch A., Cronauer M. V., Radmayr C., Trapman J., Hittmair A., Bartsch G. and Klocker H., Androgen receptor activation in prostatic tumor cell lines by insulin-like growth factor-I, keratinocyte growth factor, and epidermal growth factor. Cancer Research 54 (1994) 5474-5478.
73. Palvimo J. J., Reinikainen P.; Ikonen T., Kallio P. J., Moilanen A. and Jänne O. A., Mutual transcriptional interference between RelA and androgen receptor. Journal of Biological Chemistry 271 (1996) 24151-24156.
74. Pfahl M., Nuclear receptor/AP-1 interaction. Endocrine Reviews 14 (1993) 651-658.
75. Shemshedini L., Knauthe R., Sassone-Corsi P., Pornon A. and Gronemeyer H., Cell-specific inhibitory and stimulatory effects of Fos and Jun on transcription activation by nuclear receptors. EMBO Journal 10 (1991) 3839-3849.
76. Bubulya A., Wise S. C., Shen X. Q., Burmeister L. A. and Shemshedini L., c-Jun can mediate androgen receptor-induced transactivation. Journal of Biological Chemistry 271 (1996) 24583-24589.
77. Pratt W. B., Interaction of hsp90 with steroid receptors: organizing some diverse observations and presenting the newest concepts. Molecular and Cellular Endocrinology 74 (1990) C69-76.
78. Smith D. F. and Toft D. O., Steroid receptors and their associated proteins. Molecular Endocrinology 7 (1993) 4-11.
79. Bohen S. P., Kralli A. and Yamamoto K. R., Hold 'em and fold 'em: chaperones and signal transduction. Science 268 (1995) 1303-1304.
80. Veldscholte J., Berrevoets C. A., Zegers N. D., van der Kwast T. H., Grootegoed J. A. and Mulder E., Hormone-induced dissociation of the androgen receptor-heat-shock protein complex: use of a new monoclonal antibody to distinguish transformed from nontransformed receptors. Biochemistry 31 (1992) 7422-7430.
81. Nemoto T., Ohara-Nemoto Y. and Ota M., Association of the 90-kDa heat shock protein does not affect the ligand-binding ability of androgen receptor. Journal of Steroid Biochemistry and Molecular Biology 42 (1992) 803-812.
82. Marivoet S., Van Dijck P., Verhoeven G. and Heyns W., Interaction of the 90-kDa heat shock protein with native and in vitro translated androgen receptor and receptor fragments. Molecular and Cellular Endocrinology 88 (1992) 165-174.
83. Hutchison K. A., Dittmar K. D., Czar M. J. and Pratt W. B., Proof that hsp70 is required for assembly of the glucocorticoid receptor into a heterocomplex with hsp90. Journal of Biological Chemistry 269 (1994) 5043-5049.
84. Caplan A. J., Langley E., Wilson E. M. and Vidal J., Hormone-dependent transactivation by the human androgen receptor is regulated by a dnaJ protein. Journal of Biological Chemistry 270 (1995) 5251-5257.
85. Chang H. C. J. and Lindquist S., Conservation of Hsp90 macromolecular complexes in Saccharomyces cerevisiae. Journal of Biological Chemistry 269 (1994) 24983-24988.
86. Ratajczak T., Carrello A., Mark P. J., Warner B. J., Simpson R. J., Moritz R. L. and House A. K., The cyclophilin component of the unactivated estrogen receptor contains a tetratricopeptide repeat domain and shares identity with p59 (FKBP59). Journal of Biological Chemistry 268 (1993) 13187-13192.
87. Hoffmann K. and Handschumacher R. E., Cyclophilin-40: evidence for a dimeric complex with hsp90. Biochemical Journal 307 (1995) 5-8.
88. Renoir J. M., Mercier-Bodard C., Hoffmann K., Le Bihan S., Ning Y. M., Sanchez E. R., Handschumacher R. E. and Baulieu E. E., Cyclosporin A potentiates the dexamethasone-induced mouse mammary tumor virus-chloramphenicol acetyltransferase activity in LMCAT cells: a possible role for different heat shock protein-binding immunophilins in glucocorticosteroid receptor-mediated gene expression. Proceedings of the National Academy of Sciences of the U.S.A. 92 (1995) 4977-4981.
89. McPhaul M. J., Marcelli M., Tilley W. D., Griffin J. E., Isidro-Gutierrez R. F. and Wilson J. D., Molecular basis of androgen resistance in a family with a qualitative abnormality of the androgen receptor and responsive to high-dose androgen therapy. Journal of Clinical Investigation 87 (1991) 1413-1421.
90. MacLean H. E., Choi W. T., Rekaris G., Warne G. L. and Zajac J. D., Abnormal androgen receptor binding affinity in subjects with Kennedy's disease (spinal and bulbar muscular atrophy). Journal of Clinical Endocrinology and Metabolism 80 (1995) 508-516.
91. Langley E., Zhou Z. X. and Wilson E. M., Evidence for an anti-parallel orientation of the ligand-activated human androgen receptor dimer. Journal of Biological Chemistry 270 (1995) 29983-29990.
92. Claessens F., Alen P., Devos P., Peeters B., Verhoeven G. and Rombauts W., The androgen-specific probasin response element 2 interacts differentially with androgen and glucocorticoid receptors. Journal of Biological Chemistry 271 (1996) 19013-19016.
93. Adler A. J., Danielsen M. and Robins D. M., Androgen-specific gene activation via a consensus glucocorticoid response element is determined by interaction with nonreceptor factors. Proceedings of the National Academy of Sciences of the U.S.A. 89 (1992) 11660-11663.
94. Adler A. J., Scheller A., Hoffman Y. and Robins D. M., Multiple components of a complex androgen-dependent enhancer. Molecular Endocrinology 5 (1991) 1587-1596.
95. Adler A. J., Scheller A. and Robins D. M., The stringency and magnitude of androgen-specific gene activation are combinatorial functions of receptor and nonreceptor binding site sequences. Molecular and Cellular Biology 13 (1993) 6326-6335.
96. Ikeda M., Wilcox E. C. and Chin W. W., Different DNA elements can modulate the conformation of thyroid hormone receptor heterodimer and its transcriptional activity. Journal of Biological Chemistry 271 (1996) 23096-23104.